Despite his size, he packs a mighty temper and bite ... the main antagonist in the first “The Bad Guys” film. Lilly Singh comes back to star as Tiffany Fluffit in “The Bad Guys.” She’s the main ...

Lilly Singh is stepping from YouTube stand-out to host on NBC late-night, replacing Carson Daly. Singh, 30, announced her new show, “A Little Late With Lilly Singh," while a guest on "The ...

Novo Nordisk A/S gains momentum with FDA approval for Wegovy and strategic pricing. Click for why Novo outshines Eli Lilly ...

The Vanity Fair Oscar after-party is always a star-studded affair, and this year’s celebration at the Wallis Annenberg Center for the Performing Arts in Beverly Hills was no exception.

Eli Lilly said on Thursday that its experimental GLP-1 pill helped patients lose 12.4% of their body weight in a late-stage study, but that was less than previous trial results for Novo Nordisk's ...

In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight loss options after a 72-week period.

Eli Lilly’s experimental oral weight loss pill helped patients lose about 12 percent of their body weight on average in a late-stage trial, the company said Thursday, positive results but still ...

Lilly's daily obesity pill, orforglipron, shows positive results in late-stage trial, with patients losing nearly 12% of body weight over 72 weeks.

Alexa Bliss has been back in WWE for several months now, but fans have yet to see the full return of the twisted Bliss that took a hiatus from the company follo ...

Eli Lilly stock dips despite strong Q2 results. Read my insights on obesity drug market dominance and why this selloff in LLY may be a buying opportunity.

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body weight.

Eli Lilly shares plunged about 14% in midday trading Thursday after the company reported less-than-stellar results of a new study of an experimental anti-obesity pill that is expected to become a ...